Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Novavax, Inc. - Common Stock (NQ:NVAX)

6.610 +0.080 (+1.23%)
Streaming Delayed Price Updated: 11:57 AM EST, Dec 18, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Novavax, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
65 66 Next >
News headline image
Trump Taps RFK Jr. For Health Secretary Role, Sends 5 Vaccine Stocks Lower ↗
Trump may appoint Robert F. Kennedy Jr. as HHS Secretary, stirring mixed reactions. Kennedy's views on vaccines could reshape policies and affect vaccine stocks. 
Via Benzinga
Topics Government
News headline image
Novavax Lowers 2024 Forecast Despite Q3 Revenue Beat, Stock Falls ↗
Novavax reports Q3 2024 sales of $84.5 million, beating estimates, with a net loss of $121 million. EPS improves, FDA approves new vaccine, and revenue guidance is lowered. 
Via Benzinga
News headline image
Earnings Scheduled For November 12, 2024 ↗
 
Via Benzinga
News headline image
Earnings Outlook For Novavax ↗
 
Via Benzinga
News headline image
Looking Into Novavax's Recent Short Interest ↗
 
Via Benzinga
News headline image
FDA Gives Green Signal To Novavax's COVID-19-Influenza Combo Vaccine Late-Stage Trial ↗
FDA lifts clinical hold on Novavax's COVID-19-influenza combo vaccine, clearing path for Phase 3 trials. Novavax to resume trial activities soon. 
Via Benzinga
News headline image
How Is The Market Feeling About Novavax? ↗
 
Via Benzinga
News headline image
Here's How Much $1000 Invested In Novavax 5 Years Ago Would Be Worth Today ↗
 
Via Benzinga
News headline image
Looking Into Novavax's Recent Short Interest ↗
 
Via Benzinga
News headline image
$1000 Invested In Novavax 5 Years Ago Would Be Worth This Much Today ↗
 
Via Benzinga
News headline image
Smaller Cap Biotechs Are In Season: How Are We Doing? ↗
SMID biotech stocks still see a lot of speculative interest except for a brief sell-off on August 5 when the XBI touched $91.The XBI is near its 2024 high in the $103 range. 
Via Talk Markets
News headline image
Why Is COVID-19 Vaccine Maker Novavax Stock Trading Lower On Wednesday? ↗
Novavax ends UK COVID-19 vaccine contract, agreeing to repay $123.8M in quarterly installments by 2027 as part of settlement. 
Via Benzinga
News headline image
NVAX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Novavax, Inc. and Encourages Investors to Contact the Firm
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
News headline image
3 Spooky Signs That You're About to Lose Your Money on a Healthcare Stock Investment ↗
Knowing these will help you avoid making suboptimal investing decisions. 
Via The Motley Fool
News headline image
This Vaccine Stock Just Dropped by 20%: Should You Buy the Dip? ↗
Let's look beyond this piece of bad news from regulators. 
Via The Motley Fool
News headline image
NVAX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation Into Novavax, Inc. and Encourages Investors to Contact the Firm
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
News headline image
How Bad Is This News for Novavax? ↗
Novavax stock fell 20% in one trading session on the news. 
Via The Motley Fool
News headline image
Robinhood, Novavax, Phunware, Lucid Group, And Tesla: Why These 5 Stocks Are On Investors' Radars Today ↗
On Wednesday, major U.S. indices saw gains, with the Dow Jones Industrial Average climbing nearly 0.8% to 43,077.70. 
Via Benzinga
Topics Stocks
News headline image
Nasdaq Moves Higher; Morgan Stanley Profit Beats Estimates ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
 
Via Benzinga
News headline image
Dow Jumps 250 Points; U.S. Bancorp Earnings Top Views ↗
 
Via Benzinga
Topics Stocks
News headline image
FDA Puts Speed Breaker On Novavax's COVID/Flu Combo Shot Trial On Concerns Related To Damaged Nerves ↗
Novavax stock dips as the FDA pauses its COVID-19-influenza vaccine trials following a serious adverse event. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
What's Going On With Novavax Stock Today? ↗
Novavax Inc (NASDAQ:NVAX) shares are bouncing around Wednesday, pulling back after popping in early trading. The company announced that it received European marketing authorization for its Nuvaxovid... 
Via Benzinga
News headline image
RPM International Posts Upbeat Earnings, Joins Joby Aviation, Ciena And Other Big Stocks Moving Higher On Wednesday ↗
 
Via Benzinga
News headline image
Biotech Stocks : Are You A Trader Or A Longer Term Investor? ↗
Biotech bull market is intact as indicated by large cap biopharma and the best performing funds. 
Via Talk Markets
News headline image
DeSantis Administration Cautions Against Pfizer, Moderna mRNA Covid Vaccines for Vulnerable Individuals, Cites Concerns Related To Rare Heart Conditions ↗
Florida advises against mRNA Covid vaccines for vulnerable residents, citing safety concerns. Gov. DeSantis' administration urges healthcare providers to prioritize alternative vaccines for seniors and... 
Via Benzinga
News headline image
Should You Buy Novavax Stock After This Regulatory Win? ↗
The biotech continues to earn important wins, but is it enough? 
Via The Motley Fool
News headline image
Why Are Novavax Shares Trading Lower Today? ↗
Novavax Inc. (NASDAQ: NVAX) shares are trading lower Thursday following multiple significant announcements. Here's what you need to know. 
Via Benzinga
News headline image
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet ↗
Here's a look at five stocks that saw increased attention from Benzinga readers during the week and the reasons why. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
65 66 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.